A critical advance in cancer study is occurring with the use of VHH fragments to re-engage damaged p53. This vital tumor protector protein is frequently inactivated in many forms of cancer, leading uncontrolled body https://bookmarkvids.com/story438483/nanobodies-revive-tumor-suppressor-p53-a-new-hope-for-malignant-therapy